Incannex Healthcare (IXHL) Net Income towards Common Stockholders (2022 - 2026)

Incannex Healthcare has disclosed Net Income towards Common Stockholders across 5 years of filings, most recently posting -$3.9 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 2.14% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at -$48.4 million (down 122.97% YoY), while the FY2025 annual figure was -$46.9 million, down 154.0% from the prior year.
• Net Income towards Common Stockholders came in at -$3.9 million for Q1 2026 at Incannex Healthcare, up from -$6.5 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$726000.0 in Q3 2023 to a low of -$31.6 million in Q2 2025.
• Average Net Income towards Common Stockholders over 5 years is -$6.6 million, with a median of -$5.3 million recorded in 2023.
• Year-over-year, Net Income towards Common Stockholders sank 646.56% in 2024 and soared 34.21% in 2025.
• Over 5 years, Net Income towards Common Stockholders stood at -$2.9 million in 2022, then plunged by 79.61% to -$5.2 million in 2023, then fell by 12.46% to -$5.9 million in 2024, then decreased by 10.64% to -$6.5 million in 2025, then soared by 40.45% to -$3.9 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$3.9 million in Q1 2026, -$6.5 million in Q4 2025, and -$6.4 million in Q3 2025.